All Issue

2021 Vol.51, Issue 2 Preview Page

Original Article

30 June 2021. pp. 74-78
Abstract
References
1

Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature 2017;543:15.

10.1038/nature.2017.2155028252092
2

Doi Y. Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections. Clin Infect Dis 2019;69:S565-75.

10.1093/cid/ciz83031724043PMC6853760
3

Stein GE, Craig WA. Tigecycline: A Critical Analysis. Clin Infect Dis 2006;43:518-24.

10.1086/50549416838243
4

D'Amato R, Thornsberry C. Calcium and magnesium in Mueller-Hinton agar and their influence on disk diffusion susceptibility results. Curr Microbiol 1979;2:135-8.

10.1007/BF02605869
5

Sun Y, Cai Y, Liu X, Bai N, Liang B, Wang R. The emergence of clinical resistance to tigecycline. Int J Antimicrob Agents 2013;41:110-6.

10.1016/j.ijantimicag.2012.09.00523127485
6

Wessels JM, Ford WE, Szymczak W, Schneider S. The Complexation of Tetracycline and Anhydrotetracycline with Mg2+ and Ca2+: A Spectroscopic Study. J Phys Chem B 1998;102:9323-31.

10.1021/jp9824050
7

Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 29th informational supplement, M100-S29. Wayne, PA: CLSI, 2019.

8

Navarro-González J, Mora-Fernández C, García-Pérez J. Clinical Implications of Disordered Magnesium Homeostasis in Chronic Renal Failure and Dialysis. Semin Dial 2009;22:37-44.

10.1111/j.1525-139X.2008.00530.x19250445
9

Pankey GA. Tigecycline. J Antimicrob Chemother 2005;56:470-80.

10.1093/jac/dki24816040625
10

Stewart AF. Clinical practice. Hypercalcemia Associated with Cancer. N Engl J Med 2005;352:373-9.

10.1056/NEJMcp04280615673803
11

Chopra I, Roberts M. Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance. Microbiol Mol Biol Rev 2001;65:232-60.

10.1128/MMBR.65.2.232-260.200111381101PMC99026
12

Thanassi DG, Suh GS, Nikaido H. Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli. J Bacteriol 1995;177:998-1007.

10.1128/jb.177.4.998-1007.19957860612PMC176695
13

Hope R, Warner M, Mushtaq S, Ward ME, Parsons T, Livermore DM. Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines. J Antimicrob Chemother 2005;56:1042-6.

10.1093/jac/dki38616286361
14

Torrico M, González N, Giménez MJ, Alou L, Sevillano D, Navarro D, et al. Influence of Media and Testing Methodology on Susceptibility to Tigecycline of Enterobacteriaceae with Reported High Tigecycline MIC. J Clin Microbiol 2010;48:2243-6.

10.1128/JCM.00119-1020351208PMC2884517
15

Deitchman AN, Singh RSP, Rand KH, Derendorf H. Enhanced in vitro activity of tigecycline in the presence of chelating agents. Int J Antimicrob Agents 2018;51:799-802.

10.1016/j.ijantimicag.2017.12.02729305959PMC5940551
16

Groisman EA, Hollands K, Kriner MA, Lee EJ, Park SY, Pontes MH. Bacterial Mg2+ Homeostasis, Transport, and Virulence. Annu Rev Genet 2013;47:625-46.

10.1146/annurev-genet-051313-05102524079267PMC4059682
17

Dominguez DC. Calcium signalling in bacteria. Mol Microbiol 2004;54:291-7.

10.1111/j.1365-2958.2004.04276.x15469503
18

Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol 2010;7:653-60.

10.1038/nrurol.2010.19021139641
Information
  • Publisher :The Korean Society for Microbiology and The Korean Society of Virology
  • Publisher(Ko) :대한미생물학회‧대한바이러스학회
  • Journal Title :JOURNAL OF BACTERIOLOGY AND VIROLOGY
  • Volume : 51
  • No :2
  • Pages :74-78
  • Received Date : 2021-05-12
  • Revised Date : 2021-06-14
  • Accepted Date : 2021-06-15